The US Food and Drug Administration (FDA) announced on Friday that an advisory panel of experts would hold meetings this month to discuss authorizing booster doses of Moderna and Johnson & Johnson's COVID-19 vaccines, and clearing Pfizer's vaccine for use in children, Reuters reports.
The panel will discuss authorizing Pfizer’s COVID-19 vaccine for children aged five through 11 on October 26, the FDA announcement said.
(Arutz Sheva’s North American desk is keeping you updated until the start of Shabbat in New York. The time posted automatically on all Arutz Sheva articles, however, is Israeli time.)
Read more